Safe and Sufficient Glycemic Control by Using a Digital Clinical Decision Support System for Patients With Type 2 Diabetes in a Routine Setting on General Hospital Wards

J Diabetes Sci Technol. 2021 Mar;15(2):231-235. doi: 10.1177/1932296820955243. Epub 2020 Sep 11.

Abstract

The aim was to investigate the applicability of a clinical decision support system in a real-world inpatient setting for patients with type 2 diabetes on general hospital wards.A total of 150 patients with type 2 diabetes requiring subcutaneous insulin therapy were treated with basal-bolus insulin therapy guided by a decision support system (GlucoTab) providing automated workflow tasks and suggestions for insulin dosing to health care professionals.By using the system, a mean daily blood glucose (BG) of 159 ± 32 mg/dL was achieved. 68.8% of measurements were in the target range (70 to <180 mg/dL). The percentage of BG values <40, <70, and ≥300 mg/dL was 0.02%, 2.2%, and 2.3%, respectively. Health care professionals' adherence to suggested insulin doses and workflow tasks was high (>93% and 91%, respectively).The decision support system facilitates safe and efficacious inpatient diabetes care by standardizing treatment workflow and providing decision support for basal-bolus insulin dosing.

Keywords: algorithm; decision support; hospital; insulin therapy; mobile applications; type 2 diabetes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Blood Glucose
  • Decision Support Systems, Clinical*
  • Diabetes Mellitus, Type 2* / drug therapy
  • Glycemic Control
  • Hospitals, General
  • Humans
  • Hypoglycemic Agents
  • Insulin

Substances

  • Blood Glucose
  • Hypoglycemic Agents
  • Insulin